Copyright Reports & Markets. All rights reserved.

Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Rabbit ALCAM ELISA Kit
    • 1.3.3 Human ALCAM ELISA Kit
    • 1.3.4 Rat ALCAM ELISA Kit
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Laboratory
    • 1.4.4 Others
  • 1.5 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Size & Forecast
    • 1.5.1 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity (2021-2032)
    • 1.5.3 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.1.4 Merck ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Fine Biotech
    • 2.2.1 Fine Biotech Details
    • 2.2.2 Fine Biotech Major Business
    • 2.2.3 Fine Biotech ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.2.4 Fine Biotech ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Fine Biotech Recent Developments/Updates
  • 2.3 Reddot Biotech Inc.
    • 2.3.1 Reddot Biotech Inc. Details
    • 2.3.2 Reddot Biotech Inc. Major Business
    • 2.3.3 Reddot Biotech Inc. ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.3.4 Reddot Biotech Inc. ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Reddot Biotech Inc. Recent Developments/Updates
  • 2.4 RayBiotech
    • 2.4.1 RayBiotech Details
    • 2.4.2 RayBiotech Major Business
    • 2.4.3 RayBiotech ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.4.4 RayBiotech ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 RayBiotech Recent Developments/Updates
  • 2.5 CUSABIO
    • 2.5.1 CUSABIO Details
    • 2.5.2 CUSABIO Major Business
    • 2.5.3 CUSABIO ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.5.4 CUSABIO ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CUSABIO Recent Developments/Updates
  • 2.6 Assay Genie
    • 2.6.1 Assay Genie Details
    • 2.6.2 Assay Genie Major Business
    • 2.6.3 Assay Genie ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.6.4 Assay Genie ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Assay Genie Recent Developments/Updates
  • 2.7 Biomatik
    • 2.7.1 Biomatik Details
    • 2.7.2 Biomatik Major Business
    • 2.7.3 Biomatik ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.7.4 Biomatik ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Biomatik Recent Developments/Updates
  • 2.8 Abbexa
    • 2.8.1 Abbexa Details
    • 2.8.2 Abbexa Major Business
    • 2.8.3 Abbexa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.8.4 Abbexa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Abbexa Recent Developments/Updates
  • 2.9 Abclonal
    • 2.9.1 Abclonal Details
    • 2.9.2 Abclonal Major Business
    • 2.9.3 Abclonal ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.9.4 Abclonal ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Abclonal Recent Developments/Updates
  • 2.10 Elabscience
    • 2.10.1 Elabscience Details
    • 2.10.2 Elabscience Major Business
    • 2.10.3 Elabscience ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.10.4 Elabscience ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Elabscience Recent Developments/Updates
  • 2.11 Shanghai Korain
    • 2.11.1 Shanghai Korain Details
    • 2.11.2 Shanghai Korain Major Business
    • 2.11.3 Shanghai Korain ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Product and Services
    • 2.11.4 Shanghai Korain ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Shanghai Korain Recent Developments/Updates

3 Competitive Environment: ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit by Manufacturer

  • 3.1 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Revenue by Manufacturer (2021-2026)
  • 3.3 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Manufacturer Market Share in 2025
    • 3.4.3 Top 6 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Manufacturer Market Share in 2025
  • 3.5 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market: Overall Company Footprint Analysis
    • 3.5.1 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market: Region Footprint
    • 3.5.2 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market: Company Product Type Footprint
    • 3.5.3 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Size by Region
    • 4.1.1 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Region (2021-2032)
    • 4.1.2 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Region (2021-2032)
    • 4.1.3 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Average Price by Region (2021-2032)
  • 4.2 North America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value (2021-2032)
  • 4.3 Europe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value (2021-2032)
  • 4.4 Asia-Pacific ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value (2021-2032)
  • 4.5 South America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value (2021-2032)
  • 4.6 Middle East & Africa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Type (2021-2032)
  • 5.2 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Type (2021-2032)
  • 5.3 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Application (2021-2032)
  • 6.2 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Application (2021-2032)
  • 6.3 Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Average Price by Application (2021-2032)

7 North America

  • 7.1 North America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Type (2021-2032)
  • 7.2 North America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Application (2021-2032)
  • 7.3 North America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Size by Country
    • 7.3.1 North America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Country (2021-2032)
    • 7.3.2 North America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Type (2021-2032)
  • 8.2 Europe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Application (2021-2032)
  • 8.3 Europe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Size by Country
    • 8.3.1 Europe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Size by Region
    • 9.3.1 Asia-Pacific ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Type (2021-2032)
  • 10.2 South America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Application (2021-2032)
  • 10.3 South America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Size by Country
    • 10.3.1 South America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Country (2021-2032)
    • 10.3.2 South America ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Size by Country
    • 11.3.1 Middle East & Africa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Drivers
  • 12.2 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Market Restraints
  • 12.3 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit
  • 13.3 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Typical Distributors
  • 14.3 ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    ALCAM ELISA Kit is an experimental tool for detecting the concentration of ALCAM (Activated Leukocyte Cell Adhesion Molecule) in human serum, blood or body fluids. ALCAM is a detailed cell membrane appendage that is widely expressed on the cell surface and is present in a variety of cell types, including leukocytes, vascular endothelial cells, and a variety of adipocytes. ALCAM is involved in a variety of physiological and pathological processes, such as cell attachment, cell migration, and the measurement of ALCAM concentration can be used to analyze and evaluate different types of activities, detail cell attachment, migration and invasion and other biological processes. The experimental tool uses alcohol-linked immunosorbent assay (ELISA) technology to calculate the concentration of ALCAM in the formula through a standard curve. This tool has important applications in clinical and laboratory research.
    This report is a detailed and comprehensive analysis for global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Fine Biotech, Reddot Biotech Inc., RayBiotech, CUSABIO, Assay Genie, Biomatik, Abbexa, Abclonal, Elabscience, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Rabbit ALCAM ELISA Kit
    Human ALCAM ELISA Kit
    Rat ALCAM ELISA Kit
    Others
    Market segment by Application
    Hospital
    Laboratory
    Others
    Major players covered
    Merck
    Fine Biotech
    Reddot Biotech Inc.
    RayBiotech
    CUSABIO
    Assay Genie
    Biomatik
    Abbexa
    Abclonal
    Elabscience
    Shanghai Korain
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit, with price, sales quantity, revenue, and global market share of ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit from 2021 to 2026.
    Chapter 3, the ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit.
    Chapter 14 and 15, to describe ALCAM(Activated Leukocyte Cell Adhesion Molecule) ELISA Kit sales channel, distributors, customers, research findings and conclusion.

    Buy now